Back
Adaptimmune Therapeutics PLC Stock Price Chart
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
11
ADAP
Adaptimmune Therapeutics PLC
Last Price:
$0.22
Seasonality Move:
19.85%
7 Day Trial
ALL ACCESS PASS
$
7
Mode Mobile Could be Next in Line"
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing slight selling pressure.
Adaptimmune Therapeutics PLC Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.26 | Sell |
| 20-day SMA: | 0.29 | Sell |
| 50-day SMA: | 0.45 | Sell |
| 200-day SMA: | 0.78 | Sell |
| 8-day EMA: | 0.25 | Sell |
| 20-day EMA: | 0.3 | Sell |
| 50-day EMA: | 0.41 | Sell |
| 200-day EMA: | 0.7 | Sell |
Adaptimmune Therapeutics PLC Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 32.01 | Sell |
| Chaikin Money Flow: | -417532 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.23 - 0.43) | Sell |
| Bollinger Bands (100): | (0.4 - 0.68) | Sell |
Adaptimmune Therapeutics PLC Technical Analysis
| Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | Apr 8 | Apr 9 | Apr 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 28 | 31 | 01 | 02 | 03 | 04 | 07 | 08 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Adaptimmune Therapeutics PLC Stock
Is Adaptimmune Therapeutics PLC Stock a Buy?
-
Adaptimmune Therapeutics PLC share price is 0.22 while ADAP 8-day simple moving average is 0.26, which is a Sell signal.
-
The stock price of ADAP is 0.22 while Adaptimmune Therapeutics PLC 20-day SMA is 0.29, which makes it a Sell.
-
Adaptimmune Therapeutics PLC 50-day simple moving average is 0.45 while ADAP share price is 0.22, making it a Sell technically.
-
ADAP stock price is 0.22 and Adaptimmune Therapeutics PLC 200-day simple moving average is 0.78, creating a Sell signal.
ADAP Technical Analysis vs Fundamental Analysis
Sell
11
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy or a Sell?
-
Adaptimmune Therapeutics PLC stock is rated a SellThe current Adaptimmune Therapeutics PLC [ADAP] share price is $0.22. The Score for ADAP is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
Adaptimmune Therapeutics PLC Stock Info
Market Cap:
55.3M
Price in USD:
0.22
Share Volume:
605.5K
Adaptimmune Therapeutics PLC 52-Week Range
52-Week High:
1.48
52-Week Low:
0.20
Sell
11
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Adaptimmune Therapeutics PLC Share Price Forecast
-
What is the Adaptimmune Therapeutics PLC stock price today?The Adaptimmune Therapeutics PLC stock price is 0.22 USD today.
-
Will ADAP stock go up or go down?Adaptimmune Therapeutics PLC> share price is forecast to RISE/FALL based on technical indicators
-
Is Adaptimmune Therapeutics PLC overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Adaptimmune Therapeutics PLC is overvalued.
Is Adaptimmune Therapeutics PLC Stock a Buy?
-
Adaptimmune Therapeutics PLC share price is 0.22 while ADAP 8-day exponential moving average is 0.25, which is a Sell signal.
-
The stock price of ADAP is 0.22 while Adaptimmune Therapeutics PLC 20-day EMA is 0.30, which makes it a Sell.
-
Adaptimmune Therapeutics PLC 50-day exponential moving average is 0.41 while ADAP share price is 0.22, making it a Sell technically.
-
ADAP stock price is 0.22 and Adaptimmune Therapeutics PLC 200-day simple moving average is 0.70, creating a Sell signal.
Fundamental Analysis of Adaptimmune Therapeutics PLC
Is Adaptimmune Therapeutics PLC a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.35 per share, and an increase next year of $0.00 per share.
Technical Analysis of Adaptimmune Therapeutics PLC
Should I short Adaptimmune Therapeutics PLC stock?
-
ADAP Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Adaptimmune Therapeutics PLC is a Sell
-
Adaptimmune Therapeutics PLC Relative Strength Index (RSI) is 32.01, which suggest Adaptimmune Therapeutics PLC is oversold
-
The Bollinger Bands (25) for Adaptimmune Therapeutics PLC is (0.23 - 0.43), which suggest Adaptimmune Therapeutics PLC is a Sell
-
The Bollinger Bands (100) for Adaptimmune Therapeutics PLC is (0.4 - 0.68), which suggest Adaptimmune Therapeutics PLC is a Sell
* Adaptimmune Therapeutics PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.